|
US5530101A
(en)
*
|
1988-12-28 |
1996-06-25 |
Protein Design Labs, Inc. |
Humanized immunoglobulins
|
|
US6596541B2
(en)
|
2000-10-31 |
2003-07-22 |
Regeneron Pharmaceuticals, Inc. |
Methods of modifying eukaryotic cells
|
|
US20040101920A1
(en)
|
2002-11-01 |
2004-05-27 |
Czeslaw Radziejewski |
Modification assisted profiling (MAP) methodology
|
|
WO2005103081A2
(en)
|
2004-04-20 |
2005-11-03 |
Genmab A/S |
Human monoclonal antibodies against cd20
|
|
US8257740B1
(en)
|
2011-08-15 |
2012-09-04 |
Gp Medical, Inc. |
Pharmaceutical composition of nanoparticles
|
|
US8246995B2
(en)
|
2005-05-10 |
2012-08-21 |
The Board Of Trustees Of The Leland Stanford Junior University |
Hydrophobic nanotubes and nanoparticles as transporters for the delivery of drugs into cells
|
|
AU2006247425A1
(en)
*
|
2005-05-16 |
2006-11-23 |
Morphotek, Inc. |
Regulated vectors for selection of cells exhibiting desired phenotypes
|
|
ES2398076T3
(es)
|
2006-06-02 |
2013-03-13 |
Regeneron Pharmaceuticals, Inc. |
Anticuerpos de alta afinidad contra el receptor de IL-6 humano
|
|
JP5161882B2
(ja)
|
2006-09-07 |
2013-03-13 |
クルセル ホランド ベー ヴェー |
インフルエンザウイルスｈ５ｎ１を中和しうるヒト結合性分子およびその使用
|
|
EP1947423A1
(en)
|
2007-01-16 |
2008-07-23 |
Sony Deutschland Gmbh |
Distance, orientation and velocity sensitive controller
|
|
JP5597128B2
(ja)
|
2007-05-11 |
2014-10-01 |
テマセック・ライフ・サイエンシズ・ラボラトリー・リミテッド |
Ｈ５トリインフルエンザの診断および監視に有用なｈ５亜型特異的結合タンパク質
|
|
SG183031A1
(en)
|
2007-09-13 |
2012-08-30 |
Temasek Life Sciences Lab Ltd |
Monoclonal antibodies specific to hemagglutinin and neuraminidase from influenza virus h5-subtype or n1-subtype and uses thereof
|
|
WO2009035412A1
(en)
|
2007-09-13 |
2009-03-19 |
Temasek Life Sciences Laboratory Limited |
Monoclonal antibodies specific to hemagglutinin from influenza virus h5-subtype and uses thereof
|
|
EP3524619A1
(en)
|
2007-12-06 |
2019-08-14 |
Dana-Farber Cancer Institute, Inc. |
Antibodies against influenza virus and methods of use thereof
|
|
US8574830B2
(en)
|
2008-02-05 |
2013-11-05 |
Temasek Life Sciences Laboratory Limited |
Binding protein and epitope-blocking ELISA for the universal detection of H5-subtype influenza viruses
|
|
WO2009121004A2
(en)
|
2008-03-28 |
2009-10-01 |
Sea Lane Biotechnologies, Llc |
Neutralizing molecules to viral antigens
|
|
US8871207B2
(en)
|
2008-07-25 |
2014-10-28 |
Humabs, LLC |
Neutralizing anti-influenza A virus antibodies and uses thereof
|
|
WO2010010467A2
(en)
|
2008-07-25 |
2010-01-28 |
Institute For Research In Biomedicine |
Neutralizing anti-influenza a virus antibodies and uses thereof
|
|
US20120128684A1
(en)
|
2008-08-25 |
2012-05-24 |
Burnham Institute For Medical Research |
Conserved Hemagglutinin Epitope, Antibodies to the Epitope and Methods of Use
|
|
WO2010074656A1
(en)
|
2008-12-24 |
2010-07-01 |
Temasek Life Sciences Laboratory Limited |
Monoclonal antibodies specific to the fusion peptide from hemagglutinin from influenza a viruses and uses thereof
|
|
JP5780762B2
(ja)
*
|
2008-12-25 |
2015-09-16 |
国立大学法人大阪大学 |
抗ヒトインフルエンザウイルス・ヒト型抗体
|
|
AU2010247530B2
(en)
|
2009-05-11 |
2016-10-13 |
Janssen Vaccines & Prevention B.V. |
Human binding molecules capable of neutralizing influenza virus H3N2 and uses thereof
|
|
CN102482345A
(zh)
|
2009-05-13 |
2012-05-30 |
航道生物技术有限责任公司 |
针对流感病毒的中和分子
|
|
JP5816170B2
(ja)
|
2009-06-26 |
2015-11-18 |
リジェネロン・ファーマシューティカルズ・インコーポレイテッドＲｅｇｅｎｅｒｏｎ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ， Ｉｎｃ． |
天然の免疫グロブリン形式を有する容易に単離される二重特異性抗体
|
|
SI2501817T2
(sl)
|
2010-02-08 |
2021-09-30 |
Regeneron Pharmaceuticals, Inc. |
Miš z navadno lahko verigo
|
|
WO2011111966A2
(en)
|
2010-03-08 |
2011-09-15 |
Celltrion, Inc. |
Human monoclonal antibodies derived from human b cells and having neutralizing activity against influenza a viruses
|
|
ES2687706T3
(es)
|
2010-06-17 |
2018-10-26 |
Trellis Bioscience, Llc |
Anticuerpos útiles en la inmunización pasiva contra la gripe
|
|
US9534042B2
(en)
|
2010-09-03 |
2017-01-03 |
Fujita Health University |
Influenza virus-neutralizing antibody and screening method therefor
|
|
WO2012045001A2
(en)
|
2010-09-30 |
2012-04-05 |
Vanderbilt University |
Influenza virus antibodies and immunogens and uses therefor
|
|
DK2731967T3
(en)
|
2011-07-14 |
2017-01-16 |
Janssen Vaccines & Prevention Bv |
HUMAN BINDING MOLECULES CAPABLE OF NEUTRALIZING INFLUENZA A VIRUS FROM PHYLOGENETIC GROUP 1 AND PHYLOGENETIC GROUP 2 AND INFLUENZA B VIRUS
|
|
ITRM20110606A1
(it)
|
2011-11-16 |
2013-05-17 |
Ist Superiore Sanita |
Peptidi della lattoferrina per lo uso come inibitori ad ampio spettro dellainfezione da virus della influenza.
|
|
JP6325451B2
(ja)
|
2011-12-02 |
2018-05-16 |
アイム・セラピューティクス・べー・フェー |
Ａ型インフルエンザに特異的な抗体
|
|
ES2686526T3
(es)
|
2011-12-05 |
2018-10-18 |
Trellis Bioscience, Llc |
Anticuerpos útiles en la inmunización pasiva contra la influenza
|
|
AU2013229488B2
(en)
|
2012-03-08 |
2017-12-07 |
Janssen Vaccines & Prevention B.V. |
Human binding molecules capable of binding to and neutralizing influenza B viruses and uses thereof
|
|
US9969794B2
(en)
|
2012-05-10 |
2018-05-15 |
Visterra, Inc. |
HA binding agents
|
|
SG10201700488QA
(en)
*
|
2012-11-13 |
2017-02-27 |
Genentech Inc |
Anti-hemagglutinin antibodies and methods of use
|
|
TWI682941B
(zh)
|
2013-02-01 |
2020-01-21 |
美商再生元醫藥公司 |
含嵌合恆定區之抗體
|
|
KR20140118682A
(ko)
*
|
2013-03-29 |
2014-10-08 |
(주)셀트리온 |
2 이상의 인플루엔자 ａ 바이러스 중화 결합 분자를 포함하는 조성물
|
|
EP3733244A1
(en)
*
|
2013-10-02 |
2020-11-04 |
Medlmmune, LLC |
Neutralizing anti-influenza a antibodies and uses thereof
|
|
JP6712428B2
(ja)
|
2014-02-04 |
2020-06-24 |
コントラフェクト コーポレイション |
インフルエンザ受動免疫に有用な抗体ならびにその使用のための組成物、組合せおよび方法
|
|
EA201691945A1
(ru)
|
2014-03-27 |
2017-02-28 |
Дженентек, Инк. |
Антитела к гемагглютинину вируса гриппа типа b и способы их применения
|
|
CN104031118B
(zh)
|
2014-06-19 |
2016-04-13 |
天津大学 |
鼠多瘤病毒衣壳粒的新型亲和肽配基及其设计筛选方法
|
|
TWI702229B
(zh)
*
|
2014-12-19 |
2020-08-21 |
美商再生元醫藥公司 |
流行性感冒病毒血球凝集素之人類抗體
|
|
US10435462B2
(en)
|
2015-03-31 |
2019-10-08 |
Viro Dynamics Corporation |
Hybrid influenza seed viruses, compositions thereof, and use thereof in the diagnosis or therapy of influenza
|
|
KR102668588B1
(ko)
*
|
2015-04-08 |
2024-05-22 |
다나-파버 캔서 인스티튜트 인크. |
인간화된 인플루엔자 모노클로날 항체 및 그의 사용 방법
|
|
CN113480640B
(zh)
|
2015-06-01 |
2024-07-30 |
免疫医疗有限责任公司 |
中和抗流感结合分子及其用途
|
|
WO2017192589A1
(en)
*
|
2016-05-02 |
2017-11-09 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Neutralizing antibodies to influenza ha and their use and identification
|
|
WO2020221450A1
(en)
|
2019-04-30 |
2020-11-05 |
Humabs Biomed Sa |
Antibodies and methods for treatment of influenza a infection
|